These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7525155)

  • 21. [Analytical study of the Abbott and Ortho tests for screening and confirmation of anti-HCV antibodies. Le groupe de Travail "Hépatites virales" de la Société Française de Transfusion Sanguine].
    Janot C; Couroucé AM; Boudart D; Cotte C; Elghouzzi MH; Jullien AM; Lemaire JM; Maisonneuve P; Maniez-Montreuil M; Mattlinger B
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):171-82. PubMed ID: 1384522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of screening and confirmation tests for antibodies to hepatitis C virus.
    Couroucé AM; Janot C
    Curr Stud Hematol Blood Transfus; 1994; (61):36-48. PubMed ID: 7525156
    [No Abstract]   [Full Text] [Related]  

  • 23. Sporadic vs. posttransfusion hepatitis C: why the differences?
    Achord JL
    Gastroenterology; 1991 Oct; 101(4):1133-4. PubMed ID: 1716237
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood donor screening for hepatitis C.
    Dusheiko GM
    S Afr Med J; 1993 Mar; 83(3):217-8. PubMed ID: 8390101
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibodies to hepatitis C and surrogate markers in blood donors.
    Koerner K; Stampe D; Glück D; Kubanek B
    Vox Sang; 1991; 61(2):138-9. PubMed ID: 1662427
    [No Abstract]   [Full Text] [Related]  

  • 26. [Serological diagnosis of anti-HCV antibodies. Tests for screening and confirmation: analytical study. Le groupe "Hépatites virales" de la Société Française de Transfusion Sanguine].
    Maniez-Montreuil M
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):163-9. PubMed ID: 1329791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The discovery of the NANB hepatitis virus by gene technology.
    Decker RH
    Beitr Infusionsther; 1992; 30():6-12. PubMed ID: 1284768
    [No Abstract]   [Full Text] [Related]  

  • 28. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing posttransfusion hepatitis.
    Takano S; Omata M; Ohto M; Satomura Y
    Hepatology; 1993 Aug; 18(2):235-9. PubMed ID: 8393422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of serologic testing for hepatitis C virus infection and risk of posttransfusion hepatitis C.
    Alter MJ
    Arch Pathol Lab Med; 1994 Apr; 118(4):342-5. PubMed ID: 7513149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.
    Yamaguchi K; Kiyokawa H; Machida J; Obayashi A; Nojiri N; Ueda S; Takatsuki K
    FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Seroprevalence of hepatitis C antiviral antibodies in blood donors in N'Djamena (Chad)].
    Massenet D; Djime O
    Bull Soc Pathol Exot; 1993; 86(4):235. PubMed ID: 7507370
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-GOR without anti-HCV core is not associated with hepatitis C viremia.
    Bååth L; Widell A
    Vox Sang; 1994; 66(2):151. PubMed ID: 7514327
    [No Abstract]   [Full Text] [Related]  

  • 33. Review of hepatitis C in Japan.
    Kiyosawa K; Furuta S
    J Gastroenterol Hepatol; 1991; 6(4):383-91. PubMed ID: 1717034
    [No Abstract]   [Full Text] [Related]  

  • 34. Routine screening of blood donations for HCV RNA.
    Araújo FM; Koch MC; Henriques I; Monteiro F; Araújo AR; Cunha-Ribeiro LM
    Vox Sang; 1998; 74(3):211. PubMed ID: 9595655
    [No Abstract]   [Full Text] [Related]  

  • 35. Prospective assessment of incidence of fulminant hepatitis in post-transfusion hepatitis: a study of 504 cases.
    Takano S; Omata M; Ohto M; Satomura Y
    Dig Dis Sci; 1994 Jan; 39(1):28-32. PubMed ID: 7506644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case report.
    Vrielink H; van der Poel CL; Reesink HW; Zaaijer HL; Lelie PN
    Vox Sang; 1995; 68(1):55-6. PubMed ID: 7536990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus infection in Japan.
    Nishioka K
    Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():152-5. PubMed ID: 1909256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Screening tests for anti-HCV antibodies: comparative results].
    Couroucé AM
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):183-91. PubMed ID: 1384523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus blood donor screening: recombinant immunoblot assay interpretation re-examined.
    Perrons CJ; Garson JA
    Vox Sang; 1993; 64(4):253. PubMed ID: 7685973
    [No Abstract]   [Full Text] [Related]  

  • 40. An easy dipstick assay for anti-core antibodies to screen blood donors for hepatitis C virus viremia.
    Mulyanto ; Suwignyo S; Tsauri S; Itoh K; Mizui M; Tsuda F; Okamoto H; Yoshizawa H; Mishiro S
    Vox Sang; 1996; 70(4):229-31. PubMed ID: 9123929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.